Selection of Blood, Blood Components, and Blood Products as Essential Medicines in 105 Low- and Middle-Income Countries-Reference-Cited by-同舟云学术

Selection of Blood, Blood Components, and Blood Products as Essential Medicines in 105 Low- and Middle-Income Countries

Published:2020-04 Issue:2 Volume:34 Page:94-100
ISSN:0887-7963
Container-title:Transfusion Medicine Reviews
language:en
Short-container-title:Transfusion Medicine Reviews

Author:

Samukange Washington T.,Gardarsdottir Helga,Leufkens Hubert G.M.,Mantel-Teeuwisse Aukje K.

Funder

German Federal Ministry of Health's Global Health Protection Programme

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology

Reference27 articles.

1. Should blood be an essential medicine?;Klein;N Engl J Med,2013

2. Improving blood safety worldwide;Lancet;The Lancet,2007

3. Geneva;World Health Organization. Global status report on blood safety and availability,2016

4. The selection and use of essential medicines: report of the WHO Expert Committee, 2013 (including the 18th WHO model list of essential medicines and the 4th WHO model list of essential medicines for children);World Health Organization,2014

5. Medicines for cancers in children: the WHO model for selection of essential medicines;Robertson;Pediatr Blood Cancer,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson’s disease models;Journal of Biomedical Science;2024-09-05

2. A Comprehensive Review on Circulating cfRNA in Plasma: Implications for Disease Diagnosis and Beyond;Diagnostics;2024-05-17

3. Frozen fresh blood plasma preserves the functionality of native human α2-macroglobulin;Scientific Reports;2023-03-20

4. Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop;Biologicals;2022-09

5. Towards equitable and sustainable availability of blood products in Zimbabwe: An analysis of strengths, weaknesses, opportunities and challenges;Transfusion Clinique et Biologique;2022-08